logo
This Weather Network anchor was 'shocked' to learn she had osteoporosis after fracturing her ankle: 'Why wasn't I warned?'

This Weather Network anchor was 'shocked' to learn she had osteoporosis after fracturing her ankle: 'Why wasn't I warned?'

Yahoo15 hours ago
Kim MacDonald, 56, says she didn't know that menopause can lead to bone density issues. Now she's warning other women to take their bone health seriously.
In March 2025, Kim MacDonald, 56, was outside of her home in Hamilton, Ont. when she stumbled over an uneven sidewalk and rolled her ankle. Since she didn't fall and could still walk, she treated it as a run-of-the-mill twisted ankle. Despite icing and elevating it, the ankle began to swell.
'I still thought at that point, OK, worst case scenario, I sprained my ankle,' MacDonald told Yahoo Canada. 'And best case scenario, I just twisted it, and the swelling will go down soon enough.'
The next day, the Weather Network anchor's foot was still quite swollen. She "hobbled" to the emergency room where an X-ray revealed that MacDonald's ankle wasn't sprained — it was broken.
'I was actually in shock," she said. "I thought, 'I didn't even do anything. How could this be broken?''
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle.
Because she injured herself in such a simple way, MacDonald's healthcare providers suggested a bone density test. Three weeks later, her general practitioner called her with some news: she had osteoporosis, a disease that causes bones to weaken and become porous.
'It was very upsetting,' she said. 'I thought that if I was to get osteoporosis, that would be something 20 years down the line. I didn't think I was going to get it at 56. I thought that's something you have when you're 76. So, I really didn't expect it. Why wasn't I warned?"
Although commonly associated with advanced age, people can develop the disease at any point in their lifetime. According to Osteoporosis Canada, men and women begin to lose bone mass in their mid-30s, however, older women are more likely to be diagnosed with the disease. Of the more than two million people living with diagnosed osteoporosis, 80 per cent are women, according to Osteoporosis Canada, and at least one in three women will suffer from an osteoporotic fracture in their lifetime.
Although hormones changes that impact bone health occur during perimenopause, post-menopausal women experience a significant drop in estrogen, which helps preserve bone density. Approximately 20 per cent of bone loss occurs during this phase of life.
Back in 2017, MacDonald was diagnosed with breast cancer, and underwent chemotherapy and radiation. after her second round of treatment, the then-48-year-old was put into medical menopause.
While MacDonald said she had an incredible health care team who saved her life, she was unaware of the impacts menopause would have on her bones.
"Nobody said anything until after I broke my ankle, years later," she said.
In June, MacDonald took to Instagram to share her osteoporosis diagnosis and help raise awareness for the realities of life after menopause.
"Knowledge is power,' MacDonald said. 'And this is one of those things that you can stop from happening.'
What is osteoporosis and why is it dangerous?
In an interview with Yahoo Canada, Dr. Lindsay Sheriff, an obstetrician and gynecologist, said osteoporosis causes bones to become so "thin and brittle" that minor falls or simply performing everyday activities can result in a fracture. Like MacDonald, many women won't know they have the disease until a fracture occurs.
Although commonly associated with advanced age, people can develop osteoporosis disease at any point in their lifetime. According to Osteoporosis Canada, men and women begin to lose bone mass in their mid-30s, however, older women are more likely to be diagnosed with the disease.
Of the more than two million people living with diagnosed osteoporosis, 80 per cent are women, according to Osteoporosis Canada, and at least one in three women will suffer from an osteoporotic fracture in their lifetime.
While most fractures can be treated, hip fractures in part hip fractures are a major concern, especially as you age. More than 20 per cent of women and 30 per cent of men who suffer a hip fracture will die within a year due to post-surgical complications like infection, blood clots and internal bleeding.
What are the risk factors for osteoporosis?
The steep decline in estrogen levels after menopause accelerate bone loss.
'This makes the perimenopausal and menopausal years a critical time for monitoring and protecting bone health,' Shirreff said.
According to Osteoporosis Canada, 80 per cent of patients with a history of fractures are not given osteoporosis therapies. That means hundreds of thousands of Canadians suffer fractures every year due to undiagnosed, untreated osteoporosis.
That's why it's important to be prepared and take precautionary measures. In Canada, routine bone density testing is recommended for all women and men aged 65 and older.
However, Shirreff said younger people may be recommended for screening if they have various risk factors, including:
Prolonged steroid use
A history of fragility fractures (fractures that occur after a low-impact event like a fall from standing height)
A family history of hip fractures
Menopause before the age of 45
Smokers
Have a high alcohol intake
'There are many circumstances where we would recommend earlier screening than the age of 65,' she said. 'It's important for you to individualize that discussion with your healthcare provider.'
How to prevent and treat osteoporosis
According to Shirreff, there are steps women can take in their 30s and 40s to help prevent osteoporosis.
Opt for calcium and vitamin-D rich foods
While calcium supplements can help prevent bone loss, you should be reaching for foods high in calcium and vitamin D like milk, cheese, yogurt beans, eggs salmon and tofu.
Add weight-bearing and resistance-based exercises to your workout
Weight-bearing exercises don't have to be complicated. Shireff said activities like walking, jogging or hiking, as well as stair climbing, tennis or pickleball can all benefit bone health as well as low-impact aerobics.
Resistance training or strength training, like weight-lifting, squats, push-ups and lunges, is also important.
'Strength training is excellent for bone health, especially for the spine and the hip,' she said. Some women wear weighted vests while walking to strengthen muscles and improve endurance and cardio fitness.
Formulate a plan with your doctor
Women should also avoid smoking and consider limiting alcohol intake to help slow down bone loss. Shirreff said it's also a good idea to ask healthcare providers about a bone density tests, especially if you went into menopause at an early age. Together, you and your health provider can discuss whether hormone therapies, supplements or other medications would be beneficial.
The good news is it's never too early to start incorporating these lifestyle and dietary habits.
'Estrogen levels go down the closer you get to menopause, so establishing healthy lifestyle and dietary habits early on — but especially during the perimenopausal time — can optimize bone health as you age,' Shirreff said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates
Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates

Yahoo

time43 minutes ago

  • Yahoo

Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates

The global recombinant human hair keratin protein market is growing quickly as more people seek effective hair health solutions and advanced wound healing treatments, says a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The global recombinant human hair keratin protein market is on a strong growth trajectory, with revenues expected to climb into the hundreds of millions by 2034. This momentum is being fueled by a rising focus on hair health, a noticeable increase in bleeding disorder cases, and a wave of fresh investments pouring into biotechnology. Together, these factors are creating fertile ground for innovation and demand across multiple industries. Companies in North America, Asia-Pacific, and Europe are actively investing in research, driving innovations, and forming partnerships to open new market opportunities. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the recombinant human hair keratin protein market in 2024. Asia Pacific is estimated to grow at the fastest CAGR during the forecast period. Market Overview & Potential Recombinant human hair keratin protein is a lab-engineered protein that replicates the structure and function of natural keratin in human hair. It is produced via recombinant DNA technology, resulting in a highly controlled and pure form of keratin that differs from traditional extracts. This makes it a valuable material for applications such as wound healing and hair care. Conventional keratin extraction methods can be inconsistent and may not yield pure products, whereas recombinant production ensures greater purity and enables precise control over the protein's amino acid sequence and structure, resulting in more predictable properties. Top Countries in Recombinant Human Hair Keratin Protein Market: United States Contribution: Leading the global market with strong demand for medical-grade recombinant keratin, supported by a robust biotech ecosystem and healthcare infrastructure. Strength: Advanced R&D capabilities and regulatory support for therapeutic and regenerative applications. China Contribution: Fastest-growing market, fueled by a rapidly expanding cosmetics and personal care sector. Strength: Strong domestic production capabilities, rising consumer awareness, and increasing investment in biotech innovations. Germany Contribution: Key contributor in Europe, especially in high-purity recombinant keratin for medical and cosmetic formulations. Strength: Expertise in biotechnology and demand for premium, high-performance personal care products. France Contribution: Strong market for cosmetic applications, particularly in haircare and skincare products incorporating natural bioactive ingredients. Strength: Sophisticated beauty industry and preference for sustainable, biologically derived ingredients. India Contribution: Emerging player in both medical and cosmetic applications of recombinant keratin. Strength: Large population base, rising demand for advanced hair and skin treatments, and growing domestic manufacturing activity. You can place an order or ask any questions, please feel free to contact us at sales@ What is the Growth Potential Responsible for The Growth of The Recombinant Human Hair Keratin Protein Market? The growth of the market is driven by the growing application in the biomedical field due to its biocompatibility, ability to promote cell growth, and biodegradability, which makes it ideal for various medical uses, driving the growth. The key applications, like tissue regeneration, drug delivery systems, and wound healing, are supporting the growth of the market. Other key drivers are biotechnology research due to the growing biotechnology sector, in personal care and cosmetics, and sustainable and ethical sourcing. Increasing incidence of chronic diseases, and government initiatives in R&D in life sciences research and development. What Are the Growing Trends Associated with the Recombinant Human Hair Keratin Protein Market? The technological advancements like innovation in synthetic biology and demonstration technology for the development of new and tailored properties, and more efficient production methods. Rising demand in the cosmetic sector for the development of hair care products for improving the shine, strengthening the damaged hair, and reducing the frizz increases the demand for the product. The growing biomedical applications, like in wound healing, tissue engineering, and drug delivery, fuel the demand for the product, supporting the growth. Shift towards sustainable and ethical products, like growing demand and interest in vegan and plant-based keratins, improves the market growth of the market. Increasing awareness and adoption due to the benefits offered and availability of the products make it a preferred choice, and increase the growth. What Is the Growing Challenge in the Recombinant Human Hair Keratin Protein Market? However, the recombinant human hair keratin protein market faces challenges including production issues, consistency concerns, and consumer perceptions. Although recombinant technology provides advantages like higher purity and specific amino acid composition, it also risks problems like misfolding, aggregation, and low yields. Additionally, high production costs, especially due to specialized equipment and chemicals, can hinder market growth. Consumer preferences for natural or plant-based products, along with safety and efficacy concerns regarding keratin treatments, could also limit market expansion. Get the latest insights on life science industry segmentation with our Annual Membership: Regional Analysis How Did North America Dominate the Recombinant Human Hair Keratin Protein Market in 2024? North America led the recombinant human hair keratin protein market in 2023. Growth is driven by increased investments, collaborations, key industry players, and advanced R&D activities. The US and Canada are the primary markets, with companies like Novus Biologicals, Abcam Ltd., PROGEN, and OriGene contributing significantly. US government initiatives to promote biotech research further boost the market, complemented by over 130 recombinant proteins approved by the US FDA for clinical use. In the UK, industries are exploring innovative methods to enhance hair growth, quality, and reduce hair fall using recombinant human hair keratin protein. Additionally, rising awareness about hair health is fueling demand for these products. What Made Asia Pacific Significantly Grow in The Recombinant Human Hair Keratin Protein Market in 2024? Asia-Pacific is expected to grow the fastest in the recombinant human hair keratin protein market during the forecast period. Market growth is driven by increasing research and development activities, rising government funding, a growing number of bleeding disorder cases, favorable infrastructure, and lower costs. Recombinant keratin has been shown to promote skin wound healing and improve blood clotting. In China, about 65,000 people suffer from hemophilia, while India has the second-largest number of hemophilia cases worldwide, with 136,000 patients. The demand for products that support hair growth and reduce hair loss is rapidly increasing in China, South Korea, and Japan. Companies like Tsubaki use recombinant human keratin to develop luxurious hair treatments that attract beauty-conscious consumers. Become a valued research partner with us - Recent Developments In July 2024, Yuhan Corp, a South Korean pharmaceutical company, signed a comprehensive R&D collaboration agreement with ProGen. The collaboration was made to strengthen next-generation biologics and drug development research. In April 2024, Bio-Techne Corporation announced a strategic distribution agreement with Thermo Fisher Scientific. The agreement will distribute Bio-Techne's innovative products, such as antibodies, proteins, immunoassay kits, reagents, and enzymes, to laboratories and research institutions across Europe. Browse More Insights of Towards Healthcare: The global GMP grade cytokines market is valued at USD 2.54 billion in 2024, expected to rise to USD 2.79 billion in 2025, and anticipated to reach approximately USD 6.48 billion by 2034. This represents a steady growth trajectory at a CAGR of 9.84% from 2025 to 2034. The global recombinant proteins market is estimated at USD 3.36 billion in 2025 and is forecasted to climb to around USD 8.08 billion by 2034, expanding at a CAGR of 10.24% over the forecast period. The recombinant lysyl endopeptidase market was valued at USD 38 million in 2023 and is projected to reach USD 67.06 million by 2034, growing at a CAGR of 5.3% between 2024 and 2034. The global hair transplant market stands at USD 7.33 billion in 2024, rising to USD 8.87 billion in 2025, with projections indicating a surge to nearly USD 49.44 billion by 2034—signaling rapid expansion. The hair treatment drug market was worth USD 1.4 billion in 2023 and is anticipated to grow to USD 2.99 billion by 2034, recording a CAGR of 7.14% during 2024–2034. The global host cell protein testing market is valued at USD 2.37 billion in 2024, estimated to increase to USD 2.56 billion in 2025, and forecasted to hit USD 5.19 billion by 2034, with an expected CAGR of 8.17% from 2025 to 2034. The global protein expression technology market is pegged at USD 2.85 billion in 2024, projected to rise to USD 3.05 billion in 2025, and likely to reach USD 5.58 billion by 2034, reflecting a CAGR of 6.94% over the forecast timeline. The global proteinase K market is valued at USD 4.82 billion in 2024, forecasted to grow to USD 5.23 billion in 2025, and set to reach USD 10.93 billion by 2034, advancing at a CAGR of 8.54% between 2025 and 2034. The global cell-free protein expression market is valued at USD 315.03 million in 2024, expected to grow to USD 342.25 million in 2025, and projected to hit USD 716.26 million by 2034, expanding at a CAGR of 8.63% from 2025 to 2034. The global protein therapeutics market is calculated at USD 375.3 billion in 2024, projected to grow to USD 401.89 billion in 2025, and expected to reach USD 740.07 billion by 2034, advancing at a CAGR of 7.08% over the forecast period. Recombinant Human Hair Keratin Protein Market Key Players Abcam Limited Abbexa, Ltd. Bon Opus Biosciences Creative Diagnostics MyBioSource, Inc. Novus Biologicals OriGene PROGEN ProSpec Wuhan Huamei Biotech Co., Ltd. Regions Covered North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: Immediate Delivery Available | Buy This Premium Research @ About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region - +44 778 256 0738 North America Region - +1 8044 4193 44 Web: Find us on social platforms: LinkedIn | Twitter | InstagramError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

New Report Shows Integrated Digital Care Breaking Through Barriers to Mental Health for Young Canadians
New Report Shows Integrated Digital Care Breaking Through Barriers to Mental Health for Young Canadians

Yahoo

time2 hours ago

  • Yahoo

New Report Shows Integrated Digital Care Breaking Through Barriers to Mental Health for Young Canadians

TORONTO, Aug. 14, 2025 /CNW/ - A new report from GreenShield reveals that digital care is transforming mental health outcomes for young Canadians. At the heart of this transformation is GreenShield+, a first-of-its-kind digital health and benefits platform that brings health coverage and care together in one seamless experience. According to GreenShield's new Health Outcomes Report: Measuring Better Health for All, more than half of Canadians under 35 who accessed digital therapy through GreenShield+ recovered from symptoms of anxiety (52%) and depression (51%)—after just three sessions. As youth mental health challenges continue to rise, the report highlights how combining health services and benefits into one integrated experience is driving real, measurable improvements. "Young Canadians are telling us—through both data and lived experience—that the current system isn't consistently meeting their needs," said Zahid Salman, President and CEO of GreenShield. "This report affirms what drives us at GreenShield: the future of health care must be integrated, inclusive, and accountable. By uniting coverage and care into one seamless experience, we're not just improving access – we're improving health outcomes for Canadians of all ages." Key insights: Young Canadians are Engaged: In Q2 2025, nearly 800,000 claims and appointments were handled through GreenShield+. Almost 1 in 3 users were under 35, showing strong demand among younger Canadians. Faster Relief Through Virtual Care: Within GreenShield+, 92 per cent of health issues were resolved in a single virtual health care visit, offering frictionless access for Canadians balancing work, school and life. Digital Cognitive Behavioural Therapy (CBT) Works: After just three sessions of digital CBT, over half of users under 35 reported recovery from symptoms of anxiety (52%) and depression (51%). Smart Therapist Matching: The advanced therapist-matching tool in GreenShield+ helps users access a counsellor within 24 hours, with a 93 per cent satisfaction rate. Better Medication Adherence: GreenShield delivered 6 per cent higher medication adherence rates than industry averages, including adherence rates of 92 per cent for asthma and 84 per cent for mental health medications. "Integrated digital care is fundamentally reshaping mental health outcomes for Canadians—not only by expanding access to services, but by delivering care that is personalized, data-informed, and responsive to individual needs," said Dr. Andrew Bond, Senior Vice President and Chief Medical Officer at GreenShield. "The findings in our report reaffirm our conviction that when care systems are connected and coordinated, they don't just improve outcomes—they empower people, strengthen communities, and transform lives." A national commitment to youth mental health As Canada's only national non-profit health and benefits company, GreenShield is doubling down on its mission of Better Health for All. Earlier this year, it launched a new social impact initiative focused on transforming youth mental health care for Canadians aged 15 to 29. A cornerstone of this initiative is GreenShield's Youth Mental Health Data Hub, Canada's most comprehensive resource providing diverse datasets on youth mental health, developed in partnership with Mental Health Research Canada. The Hub provides real-time insights, available free of charge to inform policy, research, and care delivery Later this year, GreenShield will launch a comprehensive youth mental health solution, designed to tackle the biggest barriers young people face: care navigation, equitable access, and affordability. By uniting coverage and care in one platform, GreenShield is not just supporting youth more effectively—it's redefining what's possible for the next generation. Coverage and care, all in one place Canadians spend 2.5 times more time navigating health care and benefits than actually receiving care. GreenShield+ is changing that. As the first-of-its-kind digital health and benefits ecosystem, GreenShield+ streamlines the health care journey, bringing health benefits and health care services including mental health services, telemedicine, pharmacy and chronic disease management into one integrated and easy-to-use platform. With GreenShield+, users can check coverage, access care, and get reimbursed—all in one place. It's a simpler, smarter way to support better health that helps Canadians spend less time navigating the healthcare system and more time taking care of their health. To read GreenShield's full Health Outcomes Report, visit: About GreenShield As Canada's only national non-profit health and benefits company, GreenShield believes health care is a right, not a privilege. We're dedicated to improving health outcomes, driving systemic change, and building a future where every Canadian can reach their full health and well-being potential. We are revolutionizing the health and benefits experience with coverage and care in one place. Through our unique integrated payer-provider ("payvider") model, we offer insurance, administer benefits and pay claims as a 'payer' while offering health services such as mental health, pharmacy, telemedicine and chronic disease management as a 'provider'. As a non-profit social enterprise without shareholders, we prioritize and reinvest our excess earnings to directly support underserved communities. Through GreenShield Cares, we've committed $75 million to improve the health of over one million Canadians by the end of 2025, focusing on mental health, essential medicines, and chronic disease management. Our scalable initiatives deliver meaningful change in pursuit of Better Health for All. GreenShield is proud to be recognized as one of Canada's Most Admired Corporate Cultures, a leading Imagine Canada Caring Company, and named on the Fortune's Change the World List. SOURCE GreenShield View original content to download multimedia: Sign in to access your portfolio

Simple, Noninvasive Eye Tracking May Flag Cognitive Decline
Simple, Noninvasive Eye Tracking May Flag Cognitive Decline

Medscape

time2 hours ago

  • Medscape

Simple, Noninvasive Eye Tracking May Flag Cognitive Decline

Naturalistic gaze patterns appear to be a simple, noninvasive, and reliable indicator of cognitive decline, new research suggested. Investigators found that gaze patterns during image viewing mirrored memory performance and distinguished healthy adults from those at risk for, or with, cognitive impairment. 'We are still in the early stages of establishing eye tracking as a marker of memory and cognitive status,' lead investigator Jordana S. Wynn, PhD, assistant professor of psychology at the University of Victoria, British Columbia, Canada, told Medscape Medical News . Although larger, more diverse, and longitudinal research validation is warranted, 'this work lays important groundwork by demonstrating that naturalistic eye movement patterns are meaningfully related to memory function,' she added. The study was published online on August 11 in the Proceedings of the National Academy of Sciences. Novel Research Because the fovea — a small, cone-dense region at the center of the retina — captures high-resolution detail only in the center of the visual field, the eyes must constantly move to sample the full environment. These movements provide a precise, noninvasive measure of how visual information is encoded and retrieved from memory. While prior research has linked certain gaze metrics to memory decline, it remains unclear how multivariate gaze patterns — considering multiple eye movement features together — relate to memory function. For the study, which researchers note is the first work to analyze how eye movements differ across a range of brain health and memory function levels, Wynn and colleagues assessed 106 individuals across five groups — young adults, healthy older adults, individuals at risk for significant cognitive decline, those with mild cognitive impairment (MCI), and those with amnesia. They hypothesized that changes in gaze patterns would correspond in a linear fashion to cognitive function from the healthiest participants to those with amnesia. The study included two experiments. In the first, participants viewed a series of 120 distinct images, each for 5 seconds, to assess 'idiosyncratic gaze similarity,' or the uniqueness of their viewing patterns. As expected, memory function declined across groups — from young adults to healthy older adults, then to the at-risk group, followed by individuals with MCI and those with amnesia, showing a 'meaningful linear relationship.' In the second experiment, investigators used the same set of images, presenting 60 images once and another 60 three times for 5 seconds each to measure 'repetitive gaze similarity.' This approach revealed whether participants consistently encoded the same image features each time on repeat viewings or if they updated their memory with different features, indicating stronger or more flexible memory encoding. The researchers found that the healthy young adult group encoded unique image features with each image presentation. In contrast, participants with decreased memory and/or hippocampal/medial temporal function tended to focus on the same features each time they saw the same image. These results confirm that memory decline is associated with reduced visual exploration, less effective updating of encoded representations over repeated exposures, and lower differentiation of the images. Exciting, but Not Surprising Wynn said she was not particularly surprised by the study findings. 'Our previous work in healthy populations provided evidence that the brain and cognitive systems supporting eye movements and memory are closely linked. In past experimental work, we found that certain gaze patterns were predictive of memory performance,' she said. Therefore, Wynn and colleagues postulated that memory decline from aging, disease, or injury would yield similar changes in eye movements. 'That our prediction was confirmed was certainly exciting, but not surprising,' she added. The investigators concluded that the results provide 'compelling evidence that naturalistic gaze patterns can serve as a sensitive marker of cognitive decline.' This research lays a foundation for future work using multivariate gaze metrics to diagnose and track memory and/or hippocampal/medial temporal lobe function, they added. It's too early to determine whether naturalistic eye movements could become a first-line screening tool for cognitive decline, Wynn said. 'The value of eye tracking compared to standard neuropsychological tests is that it is noninvasive, cost-effective, and perhaps most importantly, universal,' she noted. Nearly anyone — regardless of age, ability, or language — can view pictures on a screen, so creating a screening tool that doesn't rely on written or verbal responses would be particularly practical, Wynn said. It is still too early to know whether naturalistic eye movements could serve as a first-line screening tool for cognitive decline. Wynn noted that eye tracking is noninvasive, cost-effective, and broadly accessible — anyone, regardless of age, ability, or language, can view images on a screen. With further refinement, she said, these measures could provide a high-resolution way to monitor memory and brain function in clinical settings. Novel Insights Commenting on the research for Medscape Medical News , Mariam Aly, PhD, acting associate professor of psychology at the University of California, Berkeley, said the study 'yields novel insights into how the way people move their eyes can contribute to, and reflect, memory impairments.' 'This elegant study uses sophisticated analyses to provide a comprehensive picture of how eye movement patterns differ across groups that span a continuum of memory abilities.' Importantly, these differences in eye movements were apparent even though participants had no explicit task, added Aly, who was not affiliated with the research. 'This means that assessment of eye movements during natural viewing of images has the potential to be developed into an important tool for detecting memory decline in clinical settings,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store